RGEN
Undervalued by 12.9% based on the discounted cash flow analysis.
Market cap | $11.14 Billion |
---|---|
Enterprise Value | $10.97 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $0.74 |
Beta | 1.41 |
Outstanding Shares | 55,771,075 |
Avg 30 Day Volume | 428,202 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 267.93 |
---|---|
PEG | -175.92 |
Price to Sales | 16.8 |
Price to Book Ratio | 5.28 |
Enterprise Value to Revenue | 17.17 |
Enterprise Value to EBIT | 456.87 |
Enterprise Value to Net Income | 263 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.29 |
No data
No data